Melvin Saltzman
Gastroenterology · Bridgeton, MONPI 1124025416
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,575 of the $2,912 with a category attached, or 88.4%. 19 manufacturers reported payments, led by AbbVie at 26.6% of the total. Reporting peaked in 2022 at $1,391 and has fallen 91.0% since, to $125 in 2024.
Across 125 payments — averaging $23.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$775
- Takeda Pharmaceuticals U.S.A., Inc.$506
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$332
- Johnson & Johnson$272
- Novo Nordisk$209
- Ironwood Pharmaceuticals, Inc$136
- plus $682 from 13 others
Across 5 payments — averaging $21,677 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$108K
What the payments were for
- Speaking & faculty fees$1505%
- Food & beverage$2,57588%
- Education$963%
- Gifts$913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $775 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $506 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $332 |
| Johnson & Johnson | 12 | $272 |
| Novo Nordisk | 2 | $209 |
| Ironwood Pharmaceuticals, Inc | 9 | $136 |
| Merck | 3 | $133 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Amgen | 7 | $117 |
| Braintree Laboratories, Inc. | 3 | $107 |
| Gilead | 3 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Shionogi Inc | 1 | $23 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
| Intercept Pharmaceuticals, Inc. | 1 | $15 |
| Redhill Biopharma Inc. | 1 | $13 |
| QOL Medical, LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,912 in reported general payments places this provider in the 60th percentile of 374 gastroenterology providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 18 | $78 |
| Omeprazole | 13 | $11 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Bridgeton
- Gregory SayukSaint Louis$1.1M
- Katie SchroederSaint Louis$730K
- David AlpersSaint Louis$616K
- Kamran QureshiLake St Louis$279K
- Laith Al MomaniKansas City$249K
- Ahmed SaeedKansas City$246K
- Parakkal DeepakSaint Louis$205K
- Bradley AndersonColumbia$194K
- Mauricio Lisker MelmanSaint Louis$179K
- Matthew CiorbaSaint Louis$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.